Literature DB >> 14697157

Management of paraneoplastic syndromes in lung cancer.

Leno Thomas1, Young Kwok, Martin J Edelman.   

Abstract

Paraneoplastic syndromes are common complications of lung cancer. Although most frequently associated with advanced disease, paraneoplastic syndromes may also occur at early stages. Occasionally, the paraneoplastic syndrome may be the presenting symptom of lung cancer. For most paraneoplastic syndromes, the best treatment is to treat the underlying malignancy. However, in many cases, treatment of moderate efficacy or urgent therapy is required. Specific recommendations for the management of the most common paraneoplastic syndromes, including cachexia, hypercalcemia, and hyponatremia, are provided.

Entities:  

Mesh:

Year:  2004        PMID: 14697157     DOI: 10.1007/s11864-004-0006-6

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  69 in total

1.  Remission of pure-red-cell aplasia associated with operative cure of lung cancer.

Authors:  T Tauchi; H Iwama; H Kaku; Y Kimura; K Ohyashiki
Journal:  Am J Hematol       Date:  1999-06       Impact factor: 10.047

2.  Additive effect of ketoconazole and octreotide in the treatment of severe adrenocorticotropin-dependent hypercortisolism.

Authors:  F Vignati; P Loli
Journal:  J Clin Endocrinol Metab       Date:  1996-08       Impact factor: 5.958

3.  Granulocytosis associated with tumor cell production of colony-stimulating activity.

Authors:  W Hocking; J Goodman; D Golde
Journal:  Blood       Date:  1983-03       Impact factor: 22.113

4.  Prevalence of digital clubbing in bronchogenic carcinoma by a new digital index.

Authors:  R P Baughman; K L Gunther; J A Buchsbaum; E E Lower
Journal:  Clin Exp Rheumatol       Date:  1998 Jan-Feb       Impact factor: 4.473

5.  Availability of iron and degree of inflammation modifies the response to recombinant human erythropoietin when treating anemia of chronic disease in patients with rheumatoid arthritis.

Authors:  D Nordström; Y Lindroth; L Marsal; I Hafström; C Henrich; S Rantapää-Dahlqvist; A Engström-Laurent; F Fyhrquist; C Friman
Journal:  Rheumatol Int       Date:  1997       Impact factor: 2.631

6.  A randomized, active-control, pilot trial of front-loaded dosing regimens of darbepoetin-alfa for the treatment of patients with anemia during chemotherapy for malignant disease.

Authors:  John A Glaspy; Jaswant Sinh Jadeja; Glen Justice; Alex Fleishman; Gregory Rossi; Alan B Colowick
Journal:  Cancer       Date:  2003-03-01       Impact factor: 6.860

7.  A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression.

Authors:  L J Suva; G A Winslow; R E Wettenhall; R G Hammonds; J M Moseley; H Diefenbach-Jagger; C P Rodda; B E Kemp; H Rodriguez; E Y Chen
Journal:  Science       Date:  1987-08-21       Impact factor: 47.728

8.  Neutralizing antibodies to human interleukin 6 reverse hypercalcemia associated with a human squamous carcinoma.

Authors:  T Yoneda; M Nakai; K Moriyama; L Scott; N Ida; T Kunitomo; G R Mundy
Journal:  Cancer Res       Date:  1993-02-15       Impact factor: 12.701

9.  Management of patients with small cell carcinoma and the syndrome of ectopic corticotropin secretion.

Authors:  F A Collichio; P D Woolf; M Brower
Journal:  Cancer       Date:  1994-03-01       Impact factor: 6.860

Review 10.  Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment.

Authors:  Douglas E Sutherland; Ilene C Weitz; Howard A Liebman
Journal:  Am J Hematol       Date:  2003-01       Impact factor: 10.047

View more
  3 in total

Review 1.  Management of common symptoms of advanced lung cancer.

Authors:  Michelle Bedor; Carla Alexander; Martin J Edelman
Journal:  Curr Treat Options Oncol       Date:  2005-01

2.  Paraneoplastic syndrome mimicking adult-onset Still's disease caused by advanced lung cancer: a case report.

Authors:  Ning Wu; Qiang Li; Chang-Xin Gu; Toqeer Ahmed; Xiao-Peng Yao
Journal:  BMC Cancer       Date:  2011-11-16       Impact factor: 4.430

3.  A 58-Year-Old Man with a Painful Gluteal Mass as the First Presentation of Metastatic Adenocarcinoma of the Lung.

Authors:  Ayesha Siddiqa; Asim Haider; Maham Mehmood; Monica Bapna
Journal:  Am J Case Rep       Date:  2021-03-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.